Certain Stock options of Outlook Therapeutics, Inc. are subject to a Lock-Up Agreement Ending on 23-JAN-2022. These Stock options will be under lockup for 61 days starting from 23-NOV-2021 to 23-JAN-2022. Details: The company have agreed to not sell any shares of our common stock or any securities convertible into or exercisable or exchangeable into share of common stock, subject to certain exceptions, for a period of 60 days after the date of this prospectus supplement unless we obtain prior written consent of the underwriter